Singapore markets close in 1 hour 15 minutes

Precision BioSciences, Inc. (DTIL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5700-0.2000 (-11.30%)
At close: 04:00PM EDT
1.5801 +0.01 (+0.64%)
After hours: 07:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 110.05M
Enterprise value 2.51M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.03
Price/book (mrq)1.58
Enterprise value/revenue 0.02
Enterprise value/EBITDA -0.08

Trading information

Stock price history

Beta (5Y monthly) 1.81
52-week change 3-87.46%
S&P500 52-week change 3-11.08%
52-week high 314.3800
52-week low 31.1100
50-day moving average 31.7674
200-day moving average 35.8437

Share statistics

Avg vol (3-month) 32.26M
Avg vol (10-day) 310.15M
Shares outstanding 562.18M
Implied shares outstanding 6N/A
Float 852.05M
% held by insiders 110.38%
% held by institutions 151.73%
Shares short (30 May 2022) 43.01M
Short ratio (30 May 2022) 43.85
Short % of float (30 May 2022) 45.19%
Short % of shares outstanding (30 May 2022) 44.84%
Shares short (prior month 28 Apr 2022) 42.77M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -39.10%
Operating margin (ttm)-46.84%

Management effectiveness

Return on assets (ttm)-13.53%
Return on equity (ttm)-62.39%

Income statement

Revenue (ttm)102.5M
Revenue per share (ttm)1.71
Quarterly revenue growth (yoy)-79.70%
Gross profit (ttm)115.53M
EBITDA -39.23M
Net income avi to common (ttm)-40.08M
Diluted EPS (ttm)-0.6700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)116.22M
Total cash per share (mrq)1.87
Total debt (mrq)8.68M
Total debt/equity (mrq)12.47
Current ratio (mrq)4.61
Book value per share (mrq)1.13

Cash flow statement

Operating cash flow (ttm)-107.8M
Levered free cash flow (ttm)-35.07M